Cybin (FRA:R7E1) ROE % Adjusted to Book Value : -83.35% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Cybin ROE % Adjusted to Book Value?

Cybin's ROE % for the quarter that ended in Dec. 2023 was -142.53%. Cybin's PB Ratio for the quarter that ended in Dec. 2023 was 1.71. Cybin's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -83.35%.

Cybin ROE % Adjusted to Book Value Historical Data

The historical data trend for Cybin's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin ROE % Adjusted to Book Value Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

ROE % Adjusted to Book Value

-31.74

-40.41

-37.98

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-47.91	-53.31	-50.89	-31.72	-83.35

Competitive Comparison of Cybin's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Cybin's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cybin's ROE % Adjusted to Book Value falls into.

Cybin ROE % Adjusted to Book Value Calculation

Cybin's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-74.06%	/	1.95
	=	-37.98%

Cybin's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-142.53%	/	1.71
	=	-83.35%

Cybin ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cybin's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CYBN:USA CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines